T-Knife Therapeutics

Biotechnology

T-Knife Therapeutics is a private biotechnology company. It has raised $110 million across 1 recorded round; the latest was an $110 million Series B in Aug 2021.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$110.0M
Last round
Later Stage VC (Series B)
Aug 2021
Valuation — not yet established

No valuation for T-Knife Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($110.0M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on T-Knife Therapeutics
  • ·18 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

T-Knife Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Aug 2021Later Stage VC (Series B)$110.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Recent activity

In the last 90 days, T-Knife Therapeutics's record added 3 institutional fund marks (latest period Jul 2026).

How much has T-Knife Therapeutics raised?

T-Knife Therapeutics has raised $110 million across 1 recorded round since 2021. The largest was an $110 million Series B in Aug 2021.

Institutional holders and vehicles

2 SEC-registered funds reported 18 fair-value marks on T-Knife Therapeutics between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

How T-Knife Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For T-Knife Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →

Frequently asked about T-Knife Therapeutics

How much has T-Knife Therapeutics raised?
T-Knife Therapeutics has raised $110.0M in total funding across 1 recorded rounds.
When did T-Knife Therapeutics last raise?
T-Knife Therapeutics last raised in Aug 2021 (Later Stage VC (Series B)), raising $110.0M.